Advanced Search

 

Study ID Status Title Patient Level Data
116493 Completed Background incidence of cardiovascular ischaemic events in treated Parkinson's disease patients in the Impact database
116498 Completed An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, i
116502 Completed An Open-Label, Randomized, Single Dose Crossover Study to Determine the Bioequivalence of Duodart® 0.5mg/0.4mg (Capsule Formulation of Dutasteride 0.5mg and Tamsulosin Hydrochloride 0.4mg) Compared to Concomitant Dosing of Avodart® 0.5mg and Omnic® 0.4mg Commercial Capsules in Healthy Male Subjects.
116511 Completed A single blind, randomized, placebo-controlled, dose escalating study to evaluate the safety, tolerability,pharmacokinetic and pharmacodynamic parameters of repeat doses of GSK2330672 in healthy volunteers, given alone and with a single day of dosing with GSK1614235
116513 Active not recruiting A phase III, randomised, open-label study comparing the combination of the BRAF inhibitor, dabrafenib and the MEK inhibitor, trametinib to the BRAF inhibitor vemurafenib in subjects with unresectable (stage IIIc) or metastatic (stage IV) BRAF V600E/K mutation positive cutaneous melanoma
116516 Completed Community based patient questionnaire survey to assess asthma control in 4 Indian cities
116519 Completed The effect of food on the pharmacokinetics of metformin given either as metformin hydrochloride SR 1000mg tablet or as a fixed dose combination of metformin hydrochloride SR 1000mg/glimepiride 2mg tablet in healthy Indian volunteers.
116524 Completed A randomized, double blind, single-dose, three-period, crossover study to investigate pharmacokinetic, safety and tolerability of Fluticasone Furoate with Umeclidinium when administered in combination and as monotherapies in adult healthy volunteer subjects Study Listed on ClinicalStudyDataRequest.com
116526 Completed Bioequivalence of two levothyroxine tablet formulations in healthy Indian volunteers: A single-dose, randomized, open-label, crossover study
116529 Completed A Phase III Randomized, Double-blind Trial Investigating the Activity of Dolutegravir 50 mg BID vs Placebo over 7 Days in HIV-1-infected Subjects with RAL/ELV resistance, Followed by an Open-label Phase with an Optimized Background Regimen
116548 Completed Retrospective Study of the Prevalence, Predictors, and Consequences of Non-Adherence with Lapatinib in Women with Metastatic Breast Cancer Who Were Previously Treated with Trastuzumab
116549 Completed Japanese smoker survey evaluating the prevalence of COPD in primary care patients.
116554 Completed Incident Type II Diabetes Mellitus Among Patients Exposed to the Combination of Pravastatin and Paroxetine
116570 Completed Evaluation of immunogenicity and safety of GSK Biologicals' Tdap booster vaccine (Boostrix™) in young adults, administered 10 years after previous Tdap boosting
116571 Completed A 12-week randomised, double-blind, parallel-group study to evaluate the anti-inflammatory effects of ADOAIR® 50/250mcg twice daily compared with placebo twice daily in Japanese subjects with chronic obstructive pulmonary disease (COPD)
116572 Completed A randomised, double-blind, double dummy, 3 way cross-over study evaluating the effects of ADOAIR 50/250mcg twice daily plus tiotropium bromide 18mcg once daily compared with the individual treatments (tiotropium bromide 18mcg alone and ADOAIR 50/250mcg alone) in the treatment of Japanese subjects with COPD Study Listed on ClinicalStudyDataRequest.com
116581 Completed A four-week Phase IIa, randomized, double-blind, placebo-controlled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of GSK1278863 in subjects with anemia associated with chronic kidney disease who are not taking recombinant human erythropoietin and are not undergoing dialysis Study Listed on ClinicalStudyDataRequest.com
116582 Completed A four-week, Phase IIa, randomized, active-controlled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of switching subjects from a stable dose of recombinant human erythropoietin to GSK1278863 in hemodialysis-dependent subjects with anemia associated with chronic kidney disease Study Listed on ClinicalStudyDataRequest.com
116585 Completed A single-center, randomized, open-label, crossover study to assess the relative bioavailability of new formulations of GSK1265744 in healthy adult subjects
116586 Completed A Phase II, Open label, Single arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients with Chronic Lymphocytic Leukemia
116592 Completed A randomized, double-blind, placebo-controlled cross-over study to determine the bronchodilator effect of a single dose of fluticasone furoate (FF)/ vilanterol (VI) 100/25 mcg combination administered in the morning in adult patients with asthma Study Listed on ClinicalStudyDataRequest.com
116595 Completed A Single Dose, Open Label, Randomized, Balanced, Crossover Study to Assess the Relative Bioavailability of ThreeFormulations and Food Effect on GSK1322322 in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
116601 Completed A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily on Cardiac Biventricular Function and Arterial Stiffness in Adults with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
116602 Completed Risk of solid organ transplant rejection following vaccination with Pandemrix™ in the United Kingdom
116604 Active not recruiting PGx6039 PGx Investigation of Pyrexia in Subjects Receiving GSK2118436 Monotherapy

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.